• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ipca Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3617.0
  • ISIN : INE571A01038
1,424.80 -45 (-3.07%)
  • As on 02 Jun 2025 (EOD)

  • Today’s Low

    1,409.00

  • Today’s High

    1,490.00

  • Open

    1,483.10

  • Perv Close

    1,470.00

  • 52W Low

    1,052.00

  • 52W High

    1,755.90

Key Indicators

  • P/E(TTM)

    43.60

  • Mar.Cap (₹Cr.)

    36,147.78

  • Div & Yield %

    0.28

  • Book Value(₹)

    265.61

  • Debt-Equity Ratio

    -3.07

  • AGM Date

    30-May-2025

  • EPS

    32.66

  • P/E Ratio

    43.60

Financials Ratios

  • Debt-Equity Ratio

    0.24

  • Mar.Cap (₹Cr.)

    36,147.78

  • RONW (%)

    8.69

  • ROCE (%)

    12.92

Score Board

  • Equity (₹ in Cr.)

    25.37

  • BV (₹)

    265.60

  • Sales( ₹ in Cr.)

    6,677.92

  • NP (in Cr.)

    834.02

  • NP Var(%)

    39.0

  • Div%

    400.0

  • CPS (₹)

    42.80

  • EPS (₹)

    32.90

  • Traded Value (₹ in Lakhs)

    36,126.21

  • 52 Week High

    1,755.90

  • 52 Week Low

    1,052.00

  • Price BSE

    1424.0

  • Price NSE

    1,425.00

  • Market Capital( in Cr.)

    36,126.21

  • P/C Ratio

    33.30

  • P/E Ratio

    43.30

  • Price Vs.BV

    32.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 6,166.46 5,814.62 5,438.30 5,139.16 4,367.43 3,633.15
Excise Duty 0.00 0.00 0.00 0.00 29.61 27.49
Net Sales 6,166.46 5,814.62 5,438.30 5,139.16 4,337.82 3,605.66
Other Income 111.29 111.19 52.92 62.24 64.69 54.59
Stock Adjustments 55.19 -104.09 126.00 170.73 155.05 106.14
Total Income 6,332.94 5,821.72 5,617.22 5,372.13 4,557.56 3,766.39
EXPENDITURE :            
Raw Materials 2,033.57 1,964.94 1,911.88 1,753.21 1,635.75 1,265.89
Power and Fuel Cost 253.33 277.21 237.44 201.48 196.82 175.25
Employee Cost 1,336.19 1,193.39 1,102.14 948.84 870.79 752.24
Other Manufacturing Expenses 356.81 311.74 279.03 225.25 198.30 168.78
Selling and Administration Expenses 846.95 812.67 612.89 551.23 523.99 511.56
Miscellaneous Expenses 314.87 236.31 179.67 113.31 149.41 142.31
Employee Benefit Expenses 1,336.19 1,193.39 1,102.14 948.84 870.79 752.24
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 5,141.72 4,796.26 4,323.05 3,793.32 3,575.06 3,016.03
Operating Profit 1,191.22 1,025.46 1,294.17 1,578.81 982.50 750.36
Interest 122.58 46.34 10.41 11.13 18.84 21.09
Gross Profit 1,068.64 979.12 1,283.76 1,567.68 963.66 729.27
Depreciation 246.48 228.63 209.65 187.72 178.69 171.88
Profit Before Tax 822.16 750.49 1,074.11 1,379.96 784.97 557.39
Current Tax 288.01 223.95 197.28 244.98 137.98 102.48
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.74 20.84 16.46 -5.79 -5.47 0.00
Reported Net Profit 530.41 505.70 860.37 1,140.77 652.46 454.91
Extraordinary Items -69.52 17.51 7.86 8.34 10.86 6.30
Adjusted Net Profit 599.93 488.19 852.51 1,132.43 641.60 448.61
Adjustment below Net Profit -1.39 -2.05 1.15 -0.16 -107.04 -1.10
P & L Balance brought forward 4,478.52 4,076.35 3,316.31 2,277.18 1,752.53 1,311.36
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 50.74 101.48 101.48 101.48 20.77 12.64
P & L Balance carried down 4,956.80 4,478.52 4,076.35 3,316.31 2,277.18 1,752.53
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 400.00 400.00 400.00 400.00 250.00 150.00
Dividend Per Share(Rs) 4.00 4.00 4.00 8.00 5.00 3.00
Earnings Per Share-Unit Curr 20.91 19.93 33.91 89.93 51.64 36.00
Earnings Per Share(Adj)-Unit Curr 20.91 19.93 33.91 44.97 25.82 18.00
Book Value 250.24 231.66 215.84 374.67 290.11 248.25
Book Value(Adj)-Unit Curr 250.24 231.66 215.84 187.34 145.06 124.13

Shareholding Pattern

  • Promoter Group

    44.72%

  • Public Share Holding

    55.28%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 95,423,418 37.61 95,423,418 7
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 18,044,054 7.11 18,044,054 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 113,467,472 44.72 113,467,472 16
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,130 0.00 130 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 27,288,798 10.76 27,280,798 218
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 14,315,292 5.64 14,315,292 15
Mutual Funds / UTI 75,179,321 29.63 75,175,321 33
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,990,787 0.78 1,990,787 26
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 118,776,328 46.82 118,762,328 294
2] Non Institution
Bodies Corporate 1,200,844 0.47 1,196,844 559
Clearing Members 6,969 0.00 6,969 10
Directors of their Relatives 43,700 0.02 43,700 2
Employees 25,000 0.01 0 11
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 8,000 0.00 8,000 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,174,800 0.46 1,172,478 2,581
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 812,390 0.32 810,390 1,399
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 17,286,516 6.81 16,564,302 83,363
Market Maker 2,000 0.00 2,000 1
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 21,056 0.01 21,056 7
Others 785,635 0.31 785,635 2
Sub Total 21,460,418 8.46 20,704,882 87,996
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 253,704,218 100.00 252,934,682 88,306

Company Background

Ipca Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ipca Laboratories Ltd
  • BSE Code : 3617.0
  • ISIN : INE571A01038

  • Incorporation Year

    1949

  • Registered Office

    48 Kandivli Industrial Estate
    Kandivli (West), Mumbai,
    Maharashtra-400067

  • Telephone

    91-22-66474444

  • FAX

    91-22-28686613

  • Chairman

    Premchand Godha

  • Managing Director

    A K Jain

  • Company Secretary

    Harish P Kamath

  • Auditor

    Natvarlal Vepari & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Ipca Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ipca Labs. 1,423.95 6,277.75 6,166.46 46.28 14.12
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92